– MaxQ AI’s ACCIPIO® ICH and stroke software will be integrated on Philips CT systems and will be available to hospitals and radiology departments throughout the U.S. and E.U.
MaxQ AI, an Israeli-based medical diagnostic AI company announced that the company’s Accipio intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. MaxQ AI will be demonstrating the company’s full suite of Accipio solutions during the upcoming Radiological Society of North America (RSNA) 2019 Annual Meeting in Chicago.
Integration Benefits & Availability
The integration of Accipio’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma, and other life-threatening conditions. The Accipio platform will be available with new Philips CT systems and as an upgrade to previously installed Philips CT systems throughout U.S. and E.U. markets.
Deep Learning to Analyze Medical Imaging Data
MaxQ AI’s ACCIPIO® ICH and Stroke Platform utilizes deep learning technologies to analyze medical imaging data such as non-contrast head CT images. The results provide deep clinical insight and actionable data in minutes that will enable physicians across the world to make faster assessments in any location, at any time. Accipio Ix™ enables automatic identification and prioritization of non-contrast head CT images with suspected ICH. Accipio Ax™ provides automatic slice-level annotation of suspected ICH. Both Accipio Ix and Ax are FDA Cleared and CE Approved.
“We are advancing patient care by co-creating with our customers to bring innovations in CT system design, workflow, radiation dose management, image quality, advanced clinical applications and improved total cost of ownership,” said Karim Boussebaa, General Manager, Computed Tomography and Advanced Molecular Imaging at Philips. “As healthcare continues to transform from a volume- to a value-based approach, and the amount of data available for each clinical decision dramatically grows, the integration of MaxQ’s Accipio AI-powered solutions with our CT systems supports our ambition to achieve the quadruple aim: improved outcomes, enhanced patient experience, increased staff satisfaction, and lowered cost of care delivery.”
